Translational Development Acquisition TDACW
NASDAQ TDACW
$1.60 -0.25 (-13.51%)
As of: Sep 9, 2026 · 2:59 PM EDT

Translational Development Acquisition (TDACW) Debt Ratio (2023 - 2026)

Translational Development Acquisition's (TDACW) quarterly Debt Ratio came in at 0.01 in Q2 2026, up 156.32% quarter-over-quarter from 0.0 in Q1 2026.

Analysis

Translational Development Acquisition (TDACW) Debt Ratio (2023 - 2026) Analysis & Trends

Translational Development Acquisition (TDACW) has reported Debt Ratio for 3 consecutive years, with 0.01 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Debt Ratio changed N/A year-over-year to 0.01; the trailing twelve-month figure through Jun 2026 stood at 0.01 (changed N/A YoY), and the FY2025 full-year result was 0.0, changed N/A from the prior year.
  • Debt Ratio advanced to 0.01 in Q2 2026 per TDACW's latest filing, from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 171.94 in Q4 2023 and bottomed at 0.0 in Q3 2025.
  • Historically, Debt Ratio has averaged 34.39 across 3 years, with a median of 0.0 in 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Evercore 11.52 Bn 9.43 Bn 975.67 Mn 0.11
2 Jefferies Financial 11.24 Bn -4.17 Bn 3.09 Bn 0.29
3 Houlihan Lokey 9.53 Bn 8.45 Bn - -
4 Cluster Group Holdings 8.00 Bn 8.00 Bn - -
5 PJT Partners 6.94 Bn 6.99 Bn 481.98 Mn -
6 Moelis 6.06 Bn 5.99 Bn - -
7 Piper Sandler Companies 5.20 Bn 5.09 Bn - 0.01
8 Lazard 4.97 Bn 3.99 Bn - 0.39
9 BRBI BR Partners 3.44 Bn 3.32 Bn 16.77 Mn 0.64
10 Translational Development Acquisition 52.67 Mn 52.58 Mn - 0.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.01
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Dec 31, 2023 171.94